Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy R1 RCM (RCM) stocks

Learn how to easily invest in R1 RCM stocks.

R1 RCM Inc
NASDAQ: RCM - USD
$25.78
+ $0.15 ( + 0.59%)
HEALTH INFORMATION SERVICES

R1 RCM is a health information services business based in the US. R1 RCM stocks (RCM.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $22.3 – a decrease of 2.42% over the previous week. R1 RCM employs 20,800 staff and has a trailing 12-month revenue of around $1.6 billion.

How to buy stocks in R1 RCM

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RCM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

R1 RCM stock price (NASDAQ:RCM)

Use our graph to track the performance of RCM stocks over time.

R1 RCM shares at a glance

Information last updated 2022-08-06.
Latest market close$25.78
52-week range$18.71 - $27.86
50-day moving average $22.35
200-day moving average $23.80
Wall St. target price$30.60
PE ratio 43.3115
Dividend yield $0 (0%)
Earnings per share (TTM) $0.61

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95–$6.95
$0 if conditions met, else $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
min $1.00, max 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
FREE TRADES
Wealthsimple
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get $25 when you open a Wealthsimple account and fund at least $150.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy R1 RCM stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

R1 RCM price performance over time

Historical closes compared with the close of $25.78 from 2022-08-12

1 week (2022-08-05) -2.42%
1 month (2022-07-14) 17.13%
3 months (2022-05-13) 14.48%
6 months (2022-02-14) 2.02%
1 year (2021-08-13) 27.62%
2 years (2020-08-14) 71.41%
3 years (2019-08-14) 114.48%
5 years (2017-08-11) 737.01%

Is R1 RCM under- or over-valued?

Valuing R1 RCM stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of R1 RCM's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

R1 RCM's P/E ratio

R1 RCM's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, R1 RCM shares trade at around 43x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

R1 RCM's PEG ratio

R1 RCM's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.994. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into R1 RCM's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

R1 RCM's EBITDA

R1 RCM's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $297.1 million.

The EBITDA is a measure of a R1 RCM's overall financial performance and is widely used to measure a its profitability.

R1 RCM financials

Revenue TTM $1.6 billion
Operating margin TTM 13.59%
Gross profit TTM $311.8 million
Return on assets TTM 4.22%
Return on equity TTM 4.03%
Profit margin 3.98%
Book value $6.61
Market capitalisation $7.4 billion

TTM: trailing 12 months

R1 RCM share dividends

We're not expecting R1 RCM to pay a dividend over the next 12 months.

Have R1 RCM's shares ever split?

R1 RCM's shares were split on 22 June 2022.

R1 RCM share price volatility

Over the last 12 months, R1 RCM's shares have ranged in value from as little as $18.71 up to $27.86. A popular way to gauge a stock's volatility is its "beta".

RCM.US volatility(beta: 0.91)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while R1 RCM's is 0.9093. This would suggest that R1 RCM's shares are less volatile than average (for this exchange).

R1 RCM overview

R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site